RIG-I acts as a tumor suppressor in melanoma via regulating the activation of the MKK/p38MAPK signaling pathway

Studies have indicated that RIG-I may act as a tumor suppressor and participate in the tumorigenesis of some malignant diseases. However, RIG-I induces distinct cellular responses via different downstream signaling pathways depending on the cell type. To investigate the biological function and under...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Rui, Lu, Shun-Yuan, Ma, Jin-Xia, Wang, Qian-Lan, Zhang, Lu, Tang, Ling-Yun, Shen, Yan, Shen, Chun-Ling, Wang, Jin-Jin, Lu, Li-Ming, Wang, Zhu-Gang, Zhang, Hong-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226095/
https://www.ncbi.nlm.nih.gov/pubmed/35416622
http://dx.doi.org/10.1007/s13577-022-00698-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226095/
https://www.ncbi.nlm.nih.gov/pubmed/35416622
http://dx.doi.org/10.1007/s13577-022-00698-1

Ejemplares similares